1-15 of 15
Otto C. Boerman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study

Marlène C.H. Hekman, Otto C. Boerman, Mirjam de Weijert, Desirée L. Bos, Egbert Oosterwijk, Hans F. Langenhuijsen, Peter F.A. Mulders, Mark Rijpkema
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (18): 4634–4642.
https://doi.org/10.1158/1078-0432.CCR-15-2937
Published: 15 September 2016
View articletitled, Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study
Open the PDF for Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study in another window
Includes: Multimedia, Supplementary data
Journal Articles

Abstract A32: Pretargeted immunoPET of CEA-expressing in intraperitoneal human colonic tumor xenografts in nude mice

Rafke Schoffelen, Robert M. Sharkey, Gerben M. Franssen, David M. Goldenberg, William J. McBride, Edmund A. Rossi, Chien-Hsing Chang, Peter Laverman, Winette T.A. Graaf, Wim J.G. Oyen, Otto C. Boerman
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): A32.
https://doi.org/10.1158/1078-0432.TCME10-A32
Published: 02 February 2016
View articletitled, Abstract A32: Pretargeted immunoPET of CEA-expressing in intraperitoneal human colonic tumor xenografts in nude mice
Journal Articles

Abstract A36: ImmunoSPECT and ImmunoPET imaging of IGF-1R expression in a model for triple negative breast cancer

Sandra Heskamp, Otto C. Boerman, Wim J.G. Oyen, Janneke D.M. Molkenboer-Kuenen, Winette T.A. van der Graaf, Hanneke W.M. van Laarhoven
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): A36.
https://doi.org/10.1158/1078-0432.TCME10-A36
Published: 02 February 2016
View articletitled, Abstract A36: ImmunoSPECT and ImmunoPET imaging of IGF-1R expression in a model for triple negative breast cancer
Journal Articles

PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging

Laura K. van Dijk, Otto C. Boerman, Johannes H.A.M. Kaanders, Johan Bussink
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16): 3602–3609.
https://doi.org/10.1158/1078-0432.CCR-15-0348
Published: 13 August 2015
View articletitled, PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging
Open the PDF for PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging in another window
Journal Articles

Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507

Emmy D.G. Fleuren, Yvonne M.H. Versleijen-Jonkers, Addy C.M. van de Luijtgaarden, Janneke D.M. Molkenboer-Kuenen, Sandra Heskamp, Melissa H.S. Roeffen, Hanneke W.M. van Laarhoven, Peter J. Houghton, Wim J.G. Oyen, Otto C. Boerman, Winette T.A. van der Graaf
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (24): 7693–7703.
https://doi.org/10.1158/1078-0432.CCR-11-1488
Published: 18 December 2011
View articletitled, Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507
Open the PDF for Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507 in another window
Includes: Supplementary data
Journal Articles

Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients

W. Joost Lesterhuis, I. Jolanda M. de Vries, Gerty Schreibelt, Annechien J.A. Lambeck, Erik H.J.G. Aarntzen, Joannes F.M. Jacobs, Nicole M. Scharenborg, Mandy W.M.M. van de Rakt, Annemiek J. de Boer, Sandra Croockewit, Michelle M. van Rossum, Roel Mus, Wim J.G. Oyen, Otto C. Boerman, Sophie Lucas, Gosse J. Adema, Cornelis J.A. Punt, Carl G. Figdor
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (17): 5725–5735.
https://doi.org/10.1158/1078-0432.CCR-11-1261
Published: 01 September 2011
View articletitled, Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients
Open the PDF for Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients in another window
Includes: Supplementary data
Journal Articles

Correlation of Segmented Metabolic Tumor Volume with Outcome - Letter

Esther G.C. Troost, Dominic A.X. Schinagl, Johan Bussink, Johannes H.A.M. Kaanders, Wim J.G. Oyen, Otto C. Boerman
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (6): 1968.
https://doi.org/10.1158/1078-0432.CCR-09-2916
Published: 14 March 2010
View articletitled, Correlation of Segmented Metabolic Tumor Volume with Outcome - Letter
Open the PDF for Correlation of Segmented Metabolic Tumor Volume with Outcome - Letter in another window
Journal Articles

Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients

Pauline Verdijk, Erik H.J.G. Aarntzen, W. Joost Lesterhuis, A.C. Inge Boullart, Ellemieke Kok, Michelle M. van Rossum, Simon Strijk, Femke Eijckeler, Johannes J. Bonenkamp, Joannes F.M. Jacobs, Willeke Blokx, J. Han J.M. vanKrieken, Irma Joosten, Otto C. Boerman, Wim J.G. Oyen, Gosse Adema, Cornelis J.A. Punt, Carl G. Figdor, I. Jolanda M. de Vries
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (7): 2531–2540.
https://doi.org/10.1158/1078-0432.CCR-08-2729
Published: 01 April 2009
View articletitled, Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients
Open the PDF for Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients in another window
Journal Articles

In vivo Molecular Prediction of Carbonic Anhydrase IX-G250MN Expression on Immunotherapy Outcome in Renal Cancer

Adrienne H. Brouwers, Otto C. Boerman, Wim J.G. Oyen
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (24): 8886.
https://doi.org/10.1158/1078-0432.CCR-05-1512
Published: 16 December 2005
View articletitled, In vivo Molecular Prediction of Carbonic Anhydrase IX-G250MN Expression on Immunotherapy Outcome in Renal Cancer
Open the PDF for In vivo Molecular Prediction of Carbonic Anhydrase IX-G250MN Expression on Immunotherapy Outcome in Renal Cancer in another window
Journal Articles

Pretargeting of Carcinoembryonic Antigen–Expressing Tumors with a Biologically Produced Bispecific Anticarcinoembryonic Antigen × Anti-Indium–Labeled Diethylenetriaminepentaacetic Acid Antibody

Frank G. van Schaijk, Egbert Oosterwijk, Annemieke C. Soede, Matthias Broekema, Cathelijne Frielink, William J. McBride, David M. Goldenberg, Frans H.M. Corstens, Otto C. Boerman
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (19): 7130s–7136s.
https://doi.org/10.1158/1078-0432.CCR-1004-0006
Published: 03 October 2005
View articletitled, Pretargeting of Carcinoembryonic Antigen–Expressing Tumors with a Biologically Produced Bispecific Anticarcinoembryonic Antigen × Anti-Indium–Labeled Diethylenetriaminepentaacetic Acid Antibody
Open the PDF for Pretargeting of Carcinoembryonic Antigen–Expressing Tumors with a Biologically Produced Bispecific Anticarcinoembryonic Antigen × Anti-Indium–Labeled Diethylenetriaminepentaacetic Acid Antibody in another window
Journal Articles

Radioimmunotherapy with [131I]cG250 in Patients with Metastasized Renal Cell Cancer: Dosimetric Analysis and Immunologic Response

Adrienne H. Brouwers, Wilhelmina C.A.M. Buijs, Peter F.A. Mulders, Pieter H.M. de Mulder, Wim J.M. van den Broek, Carola Mala, Egbert Oosterwijk, Otto C. Boerman, Frans H.M. Corstens, Wim J.G. Oyen
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (19): 7178s–7186s.
https://doi.org/10.1158/1078-0432.CCR-1004-0010
Published: 03 October 2005
View articletitled, Radioimmunotherapy with [131I]cG250 in Patients with Metastasized Renal Cell Cancer: Dosimetric Analysis and Immunologic Response
Open the PDF for Radioimmunotherapy with [131I]cG250 in Patients with Metastasized Renal Cell Cancer: Dosimetric Analysis and Immunologic Response in another window
Journal Articles

Targeting of Metastatic Renal Cell Carcinoma with the Chimeric Monoclonal Antibody G250 Labeled with 131I or 111In: An Intrapatient Comparison

Adrienne H. Brouwers, Wilhelmina C. A. M. Buijs, Egbert Oosterwijk, Otto C. Boerman, Carola Mala, Pieter H. M. De Mulder, Frans H. M. Corstens, Peter F. A. Mulders, Wim J. G. Oyen
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3953s–3960s.
Published: 01 September 2003
View articletitled, Targeting of Metastatic Renal Cell Carcinoma with the Chimeric Monoclonal Antibody G250 Labeled with 131I or 111In: An Intrapatient Comparison
Open the PDF for Targeting of Metastatic Renal Cell Carcinoma with the Chimeric Monoclonal Antibody G250 Labeled with 131I or 111In: An Intrapatient Comparison in another window
Journal Articles

Final Results of a Phase I Radioimmunotherapy Trial Using 186Re-Epratuzumab for the Treatment of Patients with Non-Hodgkin’s Lymphoma

Ernst J. Postema, John M. M. Raemaekers, Wim J. G. Oyen, Otto C. Boerman, Caroline M. P. W. Mandigers, David M. Goldenberg, Guus A. M. S. van Dongen, Frans H. M. Corstens
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3995s–4002s.
Published: 01 September 2003
View articletitled, Final Results of a Phase I Radioimmunotherapy Trial Using 186Re-Epratuzumab for the Treatment of Patients with Non-Hodgkin’s Lymphoma
Open the PDF for Final Results of a Phase I Radioimmunotherapy Trial Using 186Re-Epratuzumab for the Treatment of Patients with Non-Hodgkin’s Lymphoma in another window
Journal Articles

Pretargeting with Labeled Bivalent Peptides Allowing the Use of Four Radionuclides: 111In, 131I, 99mTc, and 188Re

Frank G. van Schaijk, Egbert Oosterwijk, Annemiele C. Soede, Wim J. G. Oyen, William J. McBride, Gary L. Griffiths, David M. Goldenberg, Frans H. M. Corstens, Otto C. Boerman
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3880s–3885s.
Published: 01 September 2003
View articletitled, Pretargeting with Labeled Bivalent Peptides Allowing the Use of Four Radionuclides: 111In, 131I, 99mTc, and 188Re
Open the PDF for Pretargeting with Labeled Bivalent Peptides Allowing the Use of Four Radionuclides: 111In, 131I, 99mTc, and 188Re in another window
Journal Articles

Phase I Radioimmunotherapy of Metastatic Renal Cell Carcinoma with 131I-labeled Chimeric Monoclonal Antibody G250

Martijn G. Steffens, Otto C. Boerman, Pieter H. M. de Mulder, Wim J. G. Oyen, Wil C. A. M. Buijs, J. Alfred Witjes, Wim J. M. van den Broek, Jeannette C. Oosterwijk-Wakka, Frans M. J. Debruyne, Frans H. M. Corstens, Egbert Oosterwijk
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (10): 3268s–3274s.
Published: 01 October 1999
View articletitled, Phase I Radioimmunotherapy of Metastatic Renal Cell Carcinoma with 131I-labeled Chimeric Monoclonal Antibody G250
Open the PDF for Phase I Radioimmunotherapy of Metastatic Renal Cell Carcinoma with 131I-labeled Chimeric Monoclonal Antibody G250 in another window